Probiotics added to metformin or insulin for gestational diabetes
Tests probiotics added to usual diabetes medicine in women with gestational diabetes.
Key facts
- Who runs it
- Riphah International University
- Where
- Pakistan1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Therapeutic Synergy of Probiotic Augmented Conventional Antidiabetic Pharmacotherapy in Gestational Diabetes Mellitus
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 29 Jul 2026
- Expected to end
- Jun 2027
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- GRP 1 Tab metformin
- GRP 2 Inj insulin
- GRP 3 Tab metformin + HI flora sachet
- GRP 4 Inj insulin + HI flora sachet
- Record updated
- 30 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women with diabetes that started in pregnancy (gestational diabetes). It compares metformin or insulin, with or without a probiotic sachet.
- Age
- 18 to 45 years
- Sex
- Women only
- Disease stage
- Gestational diabetes diagnosed between 18-26 weeks of pregnancy. Pregnant with one baby only.
- Earlier treatment
- Cannot join if antibiotics or probiotics were used within the previous 4 weeks.
Main reasons for not taking part
- Diabetes that existed before the pregnancy
- High blood pressure caused by pregnancy
- Long-term bowel, liver or kidney disease
- Pregnant with more than one baby
- Known abnormalities in the unborn baby
This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant women (18-45 years of age).
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Pregnant women (18-45 years of age)
- Diagnosed with GDM between 18-26 weeks of gestation
- Singleton pregnancy. (Multiple gestations carry inherently higher risks like preterm birth, growth restriction and neonatal morbidity, Inclusion may introduce confounding thus restricting singleton pregnancies ensures population homogeneity)
Who cannot take part
- Use of antibiotics or probiotics within the previous 4 weeks
- Pre-existing diabetes mellitus
- Pregnancy induced hypertension
- Chronic gastrointestinal, hepatic, or renal disease
- Multiple pregnancy
- Pregnancy with known fetal anomalies
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
1. To compare the effects of metformin, insulin, and their combination with multistrain probiotics on glycemic control and insulin resistance in women with gestational diabetes mellitus (GDM), assessed by FPG, HbA1c, fasting insulin, and HOMA-IR. 2. To compare the effects of metformin, insulin, and their combination with multistrain probiotics on inflammatory biomarkers in women with GDM. 3. To determine the effect of multistrain probiotic supplementation alongside standard therapy on maternal and neonatal outcomes, including gestational age at delivery, mode of delivery, birth weight, Apgar score, and NICU admission.
The 4 groups in the trial
- GRP 1 Tab metforminExisting treatment, for comparison
- GRP 2 Inj insulinExisting treatment, for comparison
- GRP 3 Tab metformin + HI flora sachetTreatment being tested
- GRP 4 Inj insulin + HI floraTreatment being tested
Treatment: GRP 4 Inj insulin + HI flora sachet
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Therapeutic Synergy of Probiotic Augmented Conventional Antidiabetic Pharmacotherapy in Gestational Diabetes Mellitus
- Plain-language title
- Probiotics added to metformin or insulin for gestational diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07645001, who can take part
- Record updated
- 30 July 2026